Aurora Cannabis Inc. Common Shares
Here’s whether Aurora Cannabis Inc. Common Shares (ACB) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.
Positives: above the 50-day MA (medium-term momentum positive); 3-month momentum positive (+10.8%). Concerns: trading below the 200-day MA (long-term downtrend); 50-day MA is falling (-2.06% over 10 days); RSI 80 — overbought, elevated pullback risk; weak 1-year return of -31.7%; rising volume on a downtrend (distribution, 1.55x avg). Currently 44.8% off its 52-week high. Score: -3/7.
ACB is trading below its 200-day MA ($3.69) — a key warning sign the longer-term trend is under pressure. With an RSI of 79.8, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of -31.7% compares to +20.4% for SPY (trailed the market by 52.1%). The current 44.8% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.